Considering the complexity of coenzyme A (CoA) metabolism and the limitations of our present understanding of disease causation, studies supporting several therapy methods for pantothenate kinase-associated neurodegeneration (PKAN) have been conducted. Here, PANK1 is linked to pantothenate kinase-associated neurodegeneration.